Drug Search by Year (Detail)

25039398

PK

Disease progression,

TRASTUZUMAB,

25039428

IN

General physical health deterioration, Disease progression, Drug ineffective,

CAPECITABINE,

25039562

IT

Disease progression, Therapy non-responder, Respiratory failure, Pneumonia,

(DAUNORUBICIN AND CYTARABINE) LIPOSOME,

25039685

US

Death, Disease progression,

LURBINECTEDIN,

25040146

IQ

Disease progression,

RITUXIMAB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CISPLATIN, CYTARABINE,

25040381

JP

Disease progression,

SACITUZUMAB GOVITECAN, PALONOSETRON HYDROCHLORIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG,

25040417

US

Disease progression, Drug ineffective,

ACALABRUTINIB, ATENOLOL, DABIGATRAN ETEXILATE MESYLATE, VENLAFAXINE HYDROCHLORIDE, FISH OIL, TAMSULOSIN HYDROCHLORIDE, MAGNESIUM, TELMISARTAN AND HYDROCHLOROTHIAZIDE, SIMVASTATIN, ERGOCALCIFEROL, VENETOCLAX,

25040559

JP

Pyrexia, Disease progression,

PEMETREXED, PEMETREXED DISODIUM, CARBOPLATIN, DOCETAXEL, DOCETAXEL ANHYDROUS, ERLOTINIB HYDROCHLORIDE, ERLOTINIB, ERLOTINIB HYDROCHLORIDE, ERLOTINIB, PEMBROLIZUMAB, RAMUCIRUMAB,

25040570

JP

Disease progression,

SACITUZUMAB GOVITECAN, PALONOSETRON HYDROCHLORIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG,

25040572

IN

Disease progression, Drug ineffective for unapproved indication,

ETOPOSIDE, IFOSFAMIDE, CARBOPLATIN,

25040599

JP

Chylothorax, Disease progression,

TRASTUZUMAB, CAPECITABINE, OXALIPLATIN, RAMUCIRUMAB, PACLITAXEL,

25040720

DE

Urinary retention, Cytokine release syndrome, Diffuse large B-cell lymphoma, Disease progression,

GLOFITAMAB, LENALIDOMIDE,

25040802

AU

Diarrhoea, Disease progression, Neuropathy peripheral, Disease recurrence, Drug ineffective, Fatigue, Nausea, Pain in extremity, Sepsis,

FLUOROURACIL, CAPECITABINE, IRINOTECAN HYDROCHLORIDE, OXALIPLATIN, SULFAMETHOXAZOLE AND TRIMETHOPRIM, BEVACIZUMAB, AMOXICILLIN, LEUCOVORIN CALCIUM,

25040818

AU

Disease progression, Therapeutic product effect incomplete,

OBINUTUZUMAB, RITUXIMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, VINCRISTINE SULFATE,

25040872

TR

Disease progression,

SACITUZUMAB GOVITECAN,

25040996

FR

Disease progression, Drug intolerance, Asthenia, Weight decreased, Drug ineffective,

FAM-TRASTUZUMAB DERUXTECAN-NXKI, FAM-TRASTUZUMAB DERUXTECAN-NXKI,

25041029

IN

Off label use, Hypertension, Respiratory rate increased, Body temperature decreased, Disease progression,

ADO-TRASTUZUMAB EMTANSINE,

25041116

US

Disease progression, Drug ineffective, Drug intolerance,

EVEROLIMUS, EVEROLIMUS TABLETS, EVEROLIMUS, EVEROLIMUS TABLETS, IMATINIB, IMATINIB,

25041135

IN

Disease progression,

GEMCITABINE HYDROCHLORIDE, GEMCITABINE,

25041139

US

Disease progression,

AMPHOTERICIN B,

25041216

IN

Disease progression, Hepatic encephalopathy, Pancytopenia, Jaundice,

GEMCITABINE HYDROCHLORIDE, GEMCITABINE, BENDAMUSTINE HCL,

25041429

IQ

Disease progression,

CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, VINCRISTINE SULFATE, PREDNISONE, IFOSFAMIDE, CARBOPLATIN, ETOPOSIDE PHOSPHATE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CYTARABINE, CISPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, OXALIPLATIN,

25041782

CA

Lung neoplasm malignant, Disease progression, Arthritis, Dysstasia, Osteoarthritis, Abscess, Fungal infection, Pain in extremity,

25042058

PL

Disease progression,

PIRFENIDONE,

25042069

RO

Ascites, Disease progression, Gastrointestinal haemorrhage, Diarrhoea, Weight decreased,

EVEROLIMUS, EVEROLIMUS TABLETS, OCTREOTIDE ACETATE, OCTREOTIDE, OCTREOTIDE ACETATE, OCTREOTIDE,

25042261

US

Death, Disease progression, Drug ineffective,

LENALIDOMIDE, ERGOCALCIFEROL, MAGNESIUM, DARATUMUMAB AND HYALURONIDASE-FIHJ (HUMAN RECOMBINANT),

25042346

DE

Atrial fibrillation, Cardiac amyloidosis, Disease progression,

TAFAMIDIS, APIXABAN, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, CANDESARTAN, SPIRONOLACTONE, DAPAGLIFLOZIN,

25042352

CA

Acute kidney injury, C-reactive protein increased, Cardiac failure, Confusional state, Congestive hepatopathy, Disease progression, Fall, Hydrocele, Hypokalaemia, Hypovolaemia, Orthostatic hypotension, Respiratory distress, Skin lesion,

SPIRONOLACTONE, SPIRONOLACTONE, SPIRONOLACTONE, SACUBITRIL AND VALSARTAN, SACUBITRIL AND VALSARTAN, SACUBITRIL AND VALSARTAN, SACUBITRIL AND VALSARTAN, FUROSEMIDE, FUROSEMIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, DEXLANSOPRAZOLE, DEXLANSOPRAZOLE, HYDROMORPHONE HYDROCHLORIDE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, FERROUS SULFATE, DALTEPARIN SODIUM, HYDROCHLOROTHIAZIDE, INSULIN HUMAN, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, MELATONIN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MIRABEGRON, MIRABEGRON, NICOTINE, TOBACCO LEAF, HYDROMORPHONE HYDROCHLORIDE, HYDROMORPHONE HYDROCHLORIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PREGABALIN, PREGABALIN, RISEDRONATE SODIUM, RISEDRONATE SODIUM, RISPERIDONE, DULOXETINE HYDROCHLORIDE, DULOXETINE,

25042397

US

Death, Pneumonia, Disease progression,

EDARAVONE, EDARAVONE,

25042479

Diffuse large B-cell lymphoma, Disease progression,

LENALIDOMIDE,

25042980

US

Prostate cancer metastatic, Disease progression, Prostatic specific antigen increased,

LUTETIUM LU 177 VIPIVOTIDE TETRAXETAN,

25043179

AU

Disease progression, Off label use, Drug ineffective, Therapeutic product effect incomplete,

PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, ETOPOSIDE, FLUDARABINE PHOSPHATE, IFOSFAMIDE, METHOTREXATE, METHOTREXATE SODIUM, NIVOLUMAB, PEMBROLIZUMAB, RITUXIMAB,

25045776

Therapy cessation, Disease progression,

PALIPERIDONE,

25034039

MX

Peripheral artery occlusion, Disease progression, Skin fissures,

IMATINIB, IMATINIB,

25034161

US

Abdominal pain, Diarrhoea, Disease progression,

GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, OXALIPLATIN, OXALIPLATIN, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ALBUTEROL SULFATE, ALBUTEROL, FAMOTIDINE, GLUCAGON, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, DEXTROSE MONOHYDRATE, DEXTROSE, ACYCLOVIR, ALLOPURINOL, ENTECAVIR, GABAPENTIN, OLANZAPINE, PANTOPRAZOLE, SENNOSIDES A AND B, PROCHLORPERAZINE, POLYETHYLENE GLYCOL 3350, FLUCONAZOLE, OXYCODONE, ALTEPLASE, FILGRASTIM, SODIUM PHOSPHATE, VANCOMYCIN HYDROCHLORIDE, VANCOMYCIN, PALONOSETRON, PALONOSETRON HYDROCHLORIDE, MORPHINE, INSULIN LISPRO, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, MAGNESIUM SULFATE, MAGNESIUM SULFATE HEPTAHYDRATE, MAGNESIUM SULFATE IN WATER FOR, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, CEFEPIME HYDROCHLORIDE, CEFEPIME, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PEGFILGRASTIM, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL,

25034165

IT

Disease progression, Cough, Pyrexia, Febrile neutropenia, Thrombocytopenia,

VENETOCLAX, AZACITIDINE, AZACITIDINE FOR,

25034280

NL

Off label use, Disease progression,

VEMURAFENIB, COBIMETINIB,

25034509

SG

Infection, Disease progression,

RITUXIMAB, RITUXIMAB, METHYLPREDNISOLONE, METHYLPREDNISOLONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, TOFACITINIB, TOFACITINIB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, NINTEDANIB,

25034537

RU

Condition aggravated, Respiratory tract infection viral, Disease progression, Hepatic steatosis, Cholecystitis chronic, Pancreatic steatosis, Spinal osteoarthritis, Nephroptosis, Pelvic fluid collection, Resorption bone increased, Paranasal cyst, Demyelination, Pleural fibrosis, Pulmonary fibrosis, Pericarditis, Neoplasm,

25034538

JP

Disease progression,

TRASTUZUMAB, METHOTREXATE, METHOTREXATE SODIUM,

25034624

IN

Disease progression,

ATEZOLIZUMAB,

25035161

IT

Disease progression, Condition aggravated,

CARBOPLATIN, ETOPOSIDE,

25035179

IT

Disease progression, Condition aggravated,

CARBOPLATIN, ETOPOSIDE,

25035181

IT

Disease progression, Condition aggravated,

CARBOPLATIN, PACLITAXEL, ATEZOLIZUMAB, BEVACIZUMAB,

25035217

PK

Therapeutic product effect incomplete, Plasma cell myeloma refractory, Gastrointestinal disorder, Disease progression,

LENALIDOMIDE, BORTEZOMIB FOR INJECTION, BORTEZOMIB, DEXAMETHASONE, DEXAMETHASONE 1.5 MG,

25035219

FR

Disease progression, Disease recurrence, Therapeutic product effect incomplete, Nephrotic syndrome, Neuropathy peripheral, Drug intolerance,

PEMETREXED, PEMETREXED DISODIUM, CARBOPLATIN, PACLITAXEL, PACLITAXEL, PEMBROLIZUMAB,

25035290

AU

Disease progression, Therapeutic product effect incomplete, Off label use,

OBINUTUZUMAB, RITUXIMAB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, VINCRISTINE SULFATE,

25035335

FR

Disease progression,

VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, ACYCLOVIR, METHYLPREDNISOLONE, FOSCARNET SODIUM, PREDNISONE,

25035367

CN

Disease progression, Drug ineffective, Drug ineffective for unapproved indication,

ETOPOSIDE, DOXORUBICIN, DOXORUBICIN, PREDNISONE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DEXAMETHASONE, DEXAMETHASONE 1.5 MG,

25035374

FR

Disease progression, Drug ineffective for unapproved indication,

TOPIRAMATE, TOPIRAMATE SPINKLE, MIGLUSTAT, CLOBAZAM,

25035390

CN

Disease progression, Drug ineffective, Drug ineffective for unapproved indication,

PREDNISONE, ETOPOSIDE, DOXORUBICIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, IFOSFAMIDE, CISPLATIN,

25035535

CN

Disease progression, Drug ineffective, Off label use,

DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CYCLOSPORINE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, METHOTREXATE, METHOTREXATE SODIUM, ETOPOSIDE, DOXORUBICIN, METHYLPREDNISOLONE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, FLUDARABINE PHOSPHATE, MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE,

25035571

CN

Disease progression, Drug ineffective for unapproved indication,

ETOPOSIDE, ETOPOSIDE, DOXORUBICIN, PREDNISONE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION,

25035575

CN

Drug ineffective for unapproved indication, Disease progression,

ETOPOSIDE, MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE, MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE, IFOSFAMIDE, MESNA, MESNA INJECTION,

25035583

CN

Disease progression, Drug ineffective, Drug ineffective for unapproved indication,

ETOPOSIDE, ETOPOSIDE, DOXORUBICIN, PREDNISONE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG,

25035599

CN

Disease progression, Drug ineffective, Drug ineffective for unapproved indication,

ETOPOSIDE, ETOPOSIDE, METHOTREXATE, METHOTREXATE SODIUM, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CISPLATIN, CISPLATIN, PEGASPARGASE, MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE, IFOSFAMIDE, MESNA, MESNA INJECTION, METHYLPREDNISOLONE, CYTARABINE,

25035653

US

Disease progression, Drug resistance,

CARBOPLATIN, SELPERCATINIB, ETOPOSIDE, NIVOLUMAB, IPILIMUMAB,

25035753

ZA

Disease progression, Drug ineffective for unapproved indication,

PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, CYCLOSPORINE, CYCLOSPORINE, AZATHIOPRINE, AZATHIOPRINE,

25035765

PK

Disease progression,

PERTUZUMAB,

25035885

SK

Invasive lobular breast carcinoma, Disease progression, Pleural fibrosis, Condition aggravated,

FULVESTRANT, PACLITAXEL, RIBOCICLIB, FULVESTRANT,

25036263

US

Palpitations, Disease progression,

OSILODROSTAT, OSILODROSTAT, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, SEMAGLUTIDE, ERGOCALCIFEROL, INSULIN GLARGINE, FAMOTIDINE,

25036275

US

Drug ineffective for unapproved indication, Disease progression, Off label use,

OCTREOTIDE ACETATE, OCTREOTIDE, OCTREOTIDE ACETATE, OCTREOTIDE, LAROTRECTINIB, LAROTRECTINIB, FLUOROURACIL, FLUOROURACIL, OXALIPLATIN, OXALIPLATIN,

25036276

DE

Disease progression, Drug ineffective,

ABIRATERONE ACETATE, ABIRATERONE, DOCETAXEL, DOCETAXEL ANHYDROUS,

25036422

CN

Pleural effusion, Metastases to lung, Disease progression,

OXALIPLATIN, LEUCOVORIN CALCIUM, FLUOROURACIL, TRASTUZUMAB,

25036428

CN

Disease progression,

DEXAMETHASONE, DEXAMETHASONE 1.5 MG, MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE, FLUDARABINE PHOSPHATE,

25036432

CN

Disease progression,

DOXORUBICIN, DOXORUBICIN, PREDNISONE, PREDNISONE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, ETOPOSIDE, ETOPOSIDE,

25036433

CN

Disease progression,

DOXORUBICIN, DOXORUBICIN, PREDNISONE, PREDNISONE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, ETOPOSIDE, ETOPOSIDE,

25036434

IN

Disease progression,

OCTREOTIDE ACETATE, OCTREOTIDE, OCTREOTIDE ACETATE,

25036438

CN

Disease progression,

CISPLATIN, CISPLATIN, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ETOPOSIDE, ETOPOSIDE, IFOSFAMIDE, IFOSFAMIDE,

25036441

CN

Disease progression,

LENALIDOMIDE, LENALIDOMIDE,

25036443

CN

Disease progression,

DOXORUBICIN, DOXORUBICIN, PREDNISONE, PREDNISONE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, ETOPOSIDE, ETOPOSIDE,

25036448

CN

Disease progression,

GEMCITABINE HYDROCHLORIDE, GEMCITABINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CISPLATIN, METHOTREXATE, METHOTREXATE SODIUM, PEGASPARGASE,

25036449

CN

Disease progression,

DOXORUBICIN, DOXORUBICIN, PREDNISONE, PREDNISONE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION,

25036495

CN

Disease progression,

DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DOXORUBICIN, DOXORUBICIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, ETOPOSIDE, ETOPOSIDE,

25036502

IN

Drug resistance, Drug ineffective, Disease progression,

IMATINIB, IMATINIB, SORAFENIB, SORAFENIB,

25036627

CN

Disease progression, Drug ineffective, Drug ineffective for unapproved indication,

ETOPOSIDE, ETOPOSIDE, DOXORUBICIN, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG,

25036641

US

Disease progression, Product use issue, Product dose omission issue,

SONIDEGIB, LISINOPRIL, GABAPENTIN,

25036662

CN

Disease progression, Drug ineffective, Drug ineffective for unapproved indication,

ETOPOSIDE, ETOPOSIDE, DOXORUBICIN, PREDNISONE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, GEMCITABINE HYDROCHLORIDE, GEMCITABINE,

25036678

CN

Disease progression, Drug ineffective for unapproved indication,

ETOPOSIDE, ETOPOSIDE, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, DOXORUBICIN, DOXORUBICIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION,

25036690

AE

Disease progression, Drug ineffective for unapproved indication, Drug ineffective, Condition aggravated,

PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, LACOSAMIDE, LACOSAMIDE, LACOSAMIDE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, PHENYTOIN, VALPROIC ACID, FUROSEMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, METHYLPREDNISOLONE, BRIVARACETAM,

25036692

US

Drug ineffective, Disease progression,

DOCETAXEL, DOCETAXEL ANHYDROUS, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CARBOPLATIN, PEMBROLIZUMAB, RAMUCIRUMAB, ENTRECTINIB, LORLATINIB, PRALSETINIB, PEMETREXED, PEMETREXED DISODIUM, VINORELBINE,

25036719

AT

Pneumococcal sepsis, Pneumonia, Disease progression, Graft versus host disease, Gastroenteritis astroviral, Dry eye, Oral herpes, Weight decreased, Dysphagia, Hepatic enzyme increased, Dyspnoea, Drug ineffective,

RITUXIMAB, POLATUZUMAB VEDOTIN, BENDAMUSTINE HCL, METHOTREXATE, METHOTREXATE SODIUM, CYTARABINE, DOLUTEGRAVIR SODIUM, BUDESONIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOXORUBICIN, CISPLATIN, PREDNISONE, METHYLPREDNISOLONE, METHYLPREDNISOLONE, BETAMETHASONE DIPROPIONATE,

25036752

CL

Drug-induced liver injury, Disease progression, Fatigue, Pyrexia, Headache,

MESALAMINE,

25036758

CN

Myelosuppression, Cytokine release syndrome, Disease progression, Haemophagocytic lymphohistiocytosis, Deep vein thrombosis, Insomnia, Granulocyte count decreased, Pyrexia, Cystitis interstitial,

POLATUZUMAB VEDOTIN, GLOFITAMAB,

25037487

KR

Disease progression, Performance status decreased,

TISLELIZUMAB-JSGR,

25037510

US

Disease progression,

FUTIBATINIB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OXYCODONE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, PROCHLORPERAZINE, SERTRALINE, DILTIAZEM HYDROCHLORIDE,

25038100

JP

Disease progression,

QUIZARTINIB,

25038352

IL

Disease progression, Therapy non-responder,

SACITUZUMAB GOVITECAN,

25038563

KR

Disease progression,

TISLELIZUMAB-JSGR,

25040858

Chronic obstructive pulmonary disease, Disease progression,

BENRALIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, ALENDRONATE SODIUM, AMLODIPINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CLONAZEPAM, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, GABAPENTIN, GEMFIBROZIL, LOSARTAN, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, MONTELUKAST SODIUM, MONTELUKAST, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, ROSUVASTATIN,

25029225

AR

Disease progression,

ZANUBRUTINIB,

25029940

MY

Disease progression, Drug ineffective,

ALECTINIB HYDROCHLORIDE,

25029985

US

Retinal oedema, Disease progression,

TEBENTAFUSP,

25030028

GB

Liver abscess, Disease progression, Blood creatinine increased,

CEMIPLIMAB-RWLC, PREDNISONE,

25030154

DK

COVID-19, Sepsis, Pyrexia, Alpha haemolytic streptococcal infection, Disease progression,

BORTEZOMIB, DOXORUBICIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION,

25030539

US

Complication associated with device, Infection, Disease progression, Adverse event, Thrombosis, Fatigue, Pain, Incoherent, Anxiety, Depression, Dysphagia, Unevaluable event,

CILTACABTAGENE AUTOLEUCEL,

25030560

PL

Disease progression,

SACITUZUMAB GOVITECAN,

25030708

IN

Disease progression,

DURVALUMAB,

25030862

IT

Disease progression,

25030896

US

Hypertension, Disease progression, Acute kidney injury, Urinary retention, Hydronephrosis, Renal pain, Retroperitoneal fibrosis, Flank pain, White blood cell count increased, Influenza,

SACITUZUMAB GOVITECAN, SACITUZUMAB GOVITECAN, ERGOCALCIFEROL, POLYETHYLENE GLYCOL 3350, SENNA LEAF,